脓毒症住院与成人后续心血管事件风险:一项基于人群的匹配队列研究
该研究为加拿大安大略省2008—2017年基于人群的匹配队列研究,纳入首次脓毒症住院的成人存活者,并按硬匹配和倾向评分与非脓毒症住院成人存活者匹配,排除既往心血管疾病者。主要复合终点为随访5年内的新发心肌梗死、卒中或心血管死亡;脓毒症存活者主要心血管事件风险增加(HR 1.30;95% CI 1.27-1.32),年龄≤40岁者HR 1.66(95% CI 1.36-2.02),>80岁者HR 1.21(95% CI 1.18-1.24)。次要终点静脉血栓栓塞(HR 1.61;95% CI 1.55-1.67)和全因死亡(HR 1.26;95% CI 1.25-1.27)风险亦增加,敏感性分析结果一致。提示脓毒症存活者出院后需关注长期心血管风险。
要点
- 成人脓毒症存活者主要心血管事件(心肌梗死、卒中或心血管死亡)风险较非脓毒症住院存活者升高(HR 1.30;95% CI 1.27-1.32)。
- 年龄≤40岁的脓毒症存活者主要心血管事件风险更高(HR 1.66;95% CI 1.36-2.02),>80岁者为HR 1.21(95% CI 1.18-1.24)。
- 脓毒症存活者静脉血栓栓塞风险升高(HR 1.61;95% CI 1.55-1.67),全因死亡风险亦升高(HR 1.26;95% CI 1.25-1.27)。
- 敏感性分析(Fine and Gray模型、概率偏倚分析)结果与主分析一致。
适用人群与场景
- 加拿大安大略省2008—2017年首次脓毒症住院的成人(>18岁)存活者,排除既往心血管疾病者。
- 对照为非脓毒症住院的成人存活者,采用硬匹配和倾向评分方法匹配。
研究设计与关键结果
- 研究类型:基于人群的匹配队列研究;254,241例成人脓毒症存活者与非脓毒症住院成人存活者匹配。
- 主要复合终点(随访5年内的心肌梗死、卒中或心血管死亡):脓毒症存活者风险较非脓毒症存活者升高(HR 1.30;95% CI 1.27-1.32)。
- 年龄亚组:≤40岁患者HR 1.66(95% CI 1.36-2.02),>80岁患者HR 1.21(95% CI 1.18-1.24)。
- 次要终点:静脉血栓栓塞HR 1.61(95% CI 1.55-1.67);全因死亡HR 1.26(95% CI 1.25-1.27)。
- 敏感性分析(Fine and Gray模型、概率偏倚分析)结果一致。
证据类型、等级与局限
- 证据类型:基于人群的匹配队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 成人脓毒症存活者出院后主要心血管事件、静脉血栓栓塞和全因死亡风险均较非脓毒症住院存活者升高,其中年龄≤40岁者主要心血管事件风险更高(HR 1.66;95% CI 1.36-2.02)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether surviving a first sepsis hospitalization is associated with long-term cardiovascular events.
METHODS: Population-based matched cohort study conducted in Ontario, Canada (2008-2017). Adult survivors (older than 18 years) of a first sepsis hospitalization were matched to adult survivors of a non-sepsis hospitalization using hard-matching and propensity score methods. Patients with pre-existing cardiovascular disease were excluded. The primary composite outcome was myocardial infarction, stroke, or cardiovascular death up to 5 years of follow-up. Secondary outcomes included venous thromboembolism and all-cause death. Cox proportional hazards models with robust standard errors were used to estimate the association of sepsis with all outcomes of interest; hazard ratios (HR) and 95% confidence intervals (CI) were calculated. Sensitivity analyses included Fine and Gray models to account for the competing risk of all-cause death and probabilistic bias analyses.
RESULTS: 254,241 adult sepsis survivors were matched to adult survivors of non-sepsis hospitalization episodes. Sepsis survivors experienced an increased hazard of major cardiovascular events compared to non-sepsis survivors (HR 1.30; 95% CI 1.27-1.32), which was more pronounced in younger patients (HR 1.66; 95% CI 1.36-2.02 for patients aged 40 or younger; HR 1.21; 95% CI 1.18-1.24 for patients older than 80 years). Sepsis survivors also faced an increased hazard of venous thromboembolism (HR 1.61; 95% CI 1.55-1.67) and all-cause death (HR 1.26; 95% CI 1.25-1.27). Sensitivity analyses yielded consistent results.
CONCLUSIONS: Adult sepsis survivors experience an increased hazard of major cardiovascular events compared to survivors of a non-sepsis hospitalization.
参考来源
- Angriman F, Rosella LC, Lawler PR, et al. Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study. Intensive Care Med. 2022. PMID: 35142896. doi:10.1007/s00134-022-06634-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。